How to Treat Metastatic Breast Cancer?

  • 2

2 Answers

These messages are for mutual support and information sharing only. Always consult your doctor before trying anything you read here.
Q: How to treat metastatic breast cancer? A: Metastatic breast cancer is not a specific type of breast cancer. It is the most dangerous and advanced stage of breast cancer. Since cancer cells have been transported to other parts of the body, it is impossible to eliminate all these cells. Although metastatic breast cancer can’t be cured, there are many ways to treat it. At this stage, cancer cells have spread to other parts of the body, but patients are still diagnosed as breast cancer and treated accordingly. For instance, if cells of breast cancer have spread to the lungs. It is still breast cancer instead of lung cancer. Patients won’t receive treatments for lung cancer, but will be given breast cancer drugs to treat the disease. The treatment depends on the specific conditions. For example, patients whose cancer is hormone receptor-positive will receive hormone therapy in the first place. If they develop HER2-positive breast cancer, they will be given anti-HER2 drugs like trastuzumab (Herceptin). In most cases, patients will undergo chemotherapy and radiation therapy, which can not only shrink or slow the growth of tumors, but also ease the relevant symptoms. Although it is the universal way to treat the disease, it may also bring along some side effects that do harm to the quality of life.     Keywords: advanced metastatic breast cancer treatment; advanced metastatic breast cancer treatments Related FAQs:
Jun 3, 2019

A UCLA-led study has found that using a drug called ribociclib in combination with a common hormone therapy may help premenopausal women with the most common type of breast cancer live longer than if they only receive the hormone therapy.

The study involved 672 women under 59 years old when it began who had advanced hormone-receptor positive/HER2- breast cancer. Seventy percent of the women who took the combination therapy were alive after 42 months, compared to 46% for women who treated with only the hormone therapy.

This trial was unique because it looks at younger women who haven't gone through menopause.